AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
• WE significantly reduced body weight, LDL-C and TC, while increased HDL-C.
• YFES increased PG and PA, while decreased PI than WE.
• A total of 50 differential lipids involved in glycerophospholipids metabolism were screened out.
• CAR C18:2 and C12:1, SM (d18:0/12:0), and SM(d18:1/14:1) were significantly upregulated in YFES.
• The improvement was related to the inhibition of SREBP-1c and Cpt1a expression levels
In this study, the impacts of egg consumption on mice model of metabolic syndrome (MetS) were comparatively investigated. Mice were divided into five groups (n=8): normal diet group (ND), high-fat diet group (HFD), HFD with whole egg group (WE), HFD with free-yolk egg substitute group (YFES), and HFD with lovastatin group (Lov). Main biochemical indexes and a non-targeted lipidomic analysis were employed to insight the lipid profile changes in serum. It was revealed that WE could significantly improve serum biochemical indexes by reducing body weight, low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC), while increasing high-density lipoprotein cholesterol. YFES exhibited remarkably better performance in increasing phosphatidylglycerol and phosphatidic acids, while decreasing phosphatidylinositol than WE. A total of 50 differential lipids biomarkers tightly related to glycerophospholipids metabolism were screened out. Carnitine C18:2 and C12:1, SM (d18:0/12:0), and SM (d18:1/14:1) were significantly upregulated in YFES compared to WE. YFES reduced expression of SREBP-1c and Cpt1a, while did not affect the expression of PPAR-α. Sphingomyelin biomarkers were positively related to the TC (|r| > 0.6), while PPAR-α was negatively correlated with triglyceride and LDL-C levels. To sum up, YFES attenuated HFD-induced MetS by improving the serum phospholipids, which account for its modulation of glycerophospholipid metabolism.
P.J. Meikle, G. Wong, C.K. Barlow, et al., Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease, Pharmacol Ther. 143(1) (2014) 12-23. https://doi.org/10.1016/j.pharmthera.2014.02.001.
A. Mozumdar, G. Liguori, Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES Ⅲ to NHANES 1999-2006, Diabetes Care 34(1) (2011) 216-219. https://doi.org/10.2337/dc10-0879.
A. Mukherjee, B.K. Mehta, K.K. Sen, et al., Metabolic syndrome-associated cognitive decline in mice: Role of minocycline, Indian J Pharmacol. 50(2) (2018) 61-68. https://doi.org/10.4103/ijp.IJP_110_18.
H. Cai, Z. Wen, X. Li, et al., Lactobacillus plantarum FRT10 alleviated high-fat diet-induced obesity in mice through regulating the PPARα signal pathway and gut microbiota, Appl. Microbiol. Biotechnol. 104(13) (2020) 5959-5972. https://doi.org/10.1007/s00253-020-10620-0.
C.J. Andersen, Bioactive egg components and inflammation, Nutrients 7(9) (2015) 7889-7913. https://doi.org/10.3390/nu7095372.
S.J. Park, J.H. Jung, S.W. Choi, et al., Association between egg consumption and metabolic disease, Korean J. Food Sci. Anim. Resour. 38(2) (2018) 209-223. https://doi.org/10.5851/kosfa.2018.38.2.209.
S. Baumgartner, E.R. Kelly, S. van der Made, et al., The influence of consuming an egg or an egg-yolk buttermilk drink for 12 wk on serum lipids, inflammation, and liver function markers in human volunteers, Nutrition 29(10) (2013) 1237-1244. https://doi.org/10.1016/j.nut.2013.03.020.
N. Sanlier, D. Üstün, Egg consumption and health effects: a narrative review, J. Food Sci. 86(10) (2021) 4250-4261. https://doi.org/10.1111/1750-3841.15892.
B. Shirouchi, R. Matsuoka, Alleviation of metabolic syndrome with dietary egg white protein, J. of Oleo Sci. 68(6) (2019) 517-524. https://doi.org/10.5650/jos.ess19084.
M.X. Wang, C.H. Wong, J.E. Kim, Impact of whole egg intake on blood pressure, lipids and lipoproteins in middle-aged and older population: a systematic review and meta-analysis of randomized controlled trials, Nutr Metab Cardiovasc Dis. 29(7) (2019) 653-664. https://doi.org/10.1016/j.numecd.2019.04.004.
C.N. Blesso, C.J. Andersen, J. Barona, et al., Effects of carbohydrate restriction and dietary cholesterol provided by eggs on clinical risk factors in metabolic syndrome, J. Clin. Lipidol. 7(5) (2013) 463-471. https://doi.org/10.1016/j.jacl.2013.03.008.
L.G. Draijer, D. Froon-Torenstra, M. van Weeghel, et al., Lipidomics in nonalcoholic fatty liver disease: exploring serum lipids as biomarkers for pediatric nonalcoholic fatty liver disease, J. Pediatr. Gastroenterol. Nutr. 71(4) (2020) 433-439. https://doi.org/10.1097/MPG.0000000000002875.
B. Comte, S. Monnerie, M. Brandolini-Bunlon, et al., Multiplatform metabolomics for an integrative exploration of metabolic syndrome in older men, EBioMedicine. 69 (2021) 103440. https://doi.org/10.1016/j.ebiom.2021.103440.
P. Almeda-Valdes, A. Altamirano-Barrera, N. Méndez-Sánchez, Insights in non-alcoholic fatty liver disease pathophysiology with lipidomic analyses, Annals of Hepatology 14(4) (2015) 567-569. https://doi.org/10.1016/s1665-2681(19)31182-2.
Z. Hall, Y. Chu, J.L. Griffin, Liquid extraction surface analysis mass spectrometry method for identifying the presence and severity of nonalcoholic fatty liver disease, Anal Chem. 89(9) (2017) 5161-5170. https://doi.org/10.1021/acs.analchem.7b01097.
C. Xu, D. Song, A.L. Holck, et al., Identifying lipid metabolites influenced by oleic acid administration using high-performance liquid chromatographymass spectrometry-based lipidomics, ACS Omega 5(20) (2020) 11314-11323. https://doi.org/10.1021/acsomega.9b04402.
I. Surowiec, R. Noordam, K. Bennett, et al., Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease, Metabolomics 15(2) (2019) 23. https://doi.org/10.1007/s11306-019-1484-7.
B. Comte, S. Monnerie, M. Brandolini-Bunlon, et al., Multiplatform metabolomics for an integrative exploration of metabolic syndrome in older men, EBioMedicine 69 (2021) 103440. https://doi.org/10.1016/j.ebiom.2021.103440.
Z. Yu, C. Mao, X. Fu, et al., High density lipoprotein from egg yolk (EYHDL) improves dyslipidemia by mediating fatty acids metabolism in high fat dietinduced obese mice, Food Sci. Anim. Resour. 39(2) (2019) 179-196. https://doi.org/10.5851/kosfa.2018.e38.
W. Wang, W. Yang, Z. Shen, et al., The dose-response effect of lycopene on cerebral vessel and neuron impairment induced by hyperlipidemia, J. Agric. Food Chem. 66(50) (2018) 13173-13182. https://doi.org/10.1021/acs.jafc.8b05232.
Shabana, S.U. Shahid, S. Sarwar, The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects, Lipids Health Dis. 19(1) (2020) 73. https://doi.org/10.1186/s12944-020-01248-0.
M.S. Hussain, N. Jahan, M.M. Or Rashid, et al., Antihyperlipidemic screening and plasma uric acid reducing potential of Momordica charantia seeds on Swiss albino mice model, Heliyon. 5(5) (2019) e01739. https://doi.org/10.1016/j.heliyon.2019.e01739.
E. Suliga, D. Kozieł, E. Cieśla, et al., Dietary patterns in relation to metabolic syndrome among adults in poland: a cross-sectional study, Nutrients. 9(12) (2017) 1366. https://doi.org/10.3390/nu9121366.
L. Bruno, M.V. Isabel, B. Christopher, et al., Intake of 3 eggs per day when compared to a choline bitartrate supplement, downregulates cholesterol synthesis without changing the LDL/HDL ratio, Nutrients 10(2) (2018) 258. https://doi:10.3390/nu10020258.
H. Wang, W. Wang, M. Shen, et al., Association between egg consumption and metabolic syndrome in Chinese population: a cross-sectional study, BMJ open 11(12) (2021) e050317. https://doi.org/10.1136/bmjopen-2021-050317.
K. Yeboah, P. Puplampu, E. Yorke, et al., Body composition and anklebrachial index in Ghanaians with asymptomatic peripheral arterial disease in a tertiary hospital, BMC Obes. 3 (2016) 27. https://doi.org/10.1186/s40608-016-0107-3.
L. Zhai, Z.W. Ning, T. Huang, et al., Cyclocarya paliurus leaves tea improves dyslipidemia in diabetic mice: a lipidomics-based network pharmacology study, Front Pharmacol. 9 (2018) 973. https://doi.org/10.3389/fphar.2018.00973.
S. Pati, S. Krishna, J.H. Lee, et al., Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice, Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 1863(1) (2018) 26-39. https://doi.org/10.1016/j.bbalip.2017.09.011.
M. Garcia-Jaramillo, M.H. Spooner, C.V. Lohr, et al., Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr-/- mice, PLoS One 14(4) (2019) e0214387. https://doi.org/10.1371/journal.pone.0214387.
M.N. Barber, S. Risis, C. Yang, et al., Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes, PLoS One 7(7) (2012) e41456. https://doi.org/10.1371/journal.pone.0041456.
H.J. Kim, J.H. Kim, S. Noh, et al., Metabolomic analysis of livers and serum from high-fat diet induced obese mice, J. Proteome. Res. 10(2) (2011) 722-731. https://doi.org/10.1021/pr100892r.
K.I. Stanford, M.D. Lynes, H. Takahashi, et al., 12,13-diHOME: an exerciseinduced lipokine that increases skeletal muscle fatty acid uptake, Cell Metab. 27(5) (2018) 1111-1120. https://doi.org/10.1016/j.cmet.2018.03.020.
F. Chiappini, A. Coilly, H. Kadar, et al., Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients, Sci. Rep. 7(2017) 46658. https://doi.org/10.1038/srep46658.
G.H. Norris, C. Jiang, J. Ryan, et al., Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice, J. Nutr. Biochem. 30 (2016) 93-101. https://doi.org/10.1016/j.jnutbio.2015.12.003.
H. Hanamatsu, S. Ohnishi, S. Sakai, et al., Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults, Nutr. Diabetes 4(10) (2014) e141. https://doi.org/10.1038/nutd.2014.38.
H.M. Park, K.T. Park, E.C. Park, et al., Mass spectrometry-based metabolomic and lipidomic analyses of the effects of dietary platycodon grandiflorum on liver and serum of obese mice under a high-fat diet, Nutrients 9(1) (2017) 71. https://doi.org/10.3390/nu9010071.
K. Anjani, M. Lhomme, N. Sokolovska, et al., Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity, J. Hepatol. 62(4) (2015) 905-912. https://doi.org/10.1016/j.jhep.2014.11.002.
X.X. Yang, J.D. Wei, J.K. Mu, et al., Integrated metabolomic profiling for analysis of antilipidemic effects of Polygonatum kingianum extract on dyslipidemia in rats, World J. Gastroenterol 24(48) (2018) 5505-5524. https://doi.org/10.3748/wjg.v24.i48.5505.
B. Nie, H.M. Park, M. Kazantzis, et al., Specific bile acids inhibit hepatic fatty acid uptake in mice, Hepatology 56(4) (2012) 1300-1310. https://doi.org/10.1002/hep.25797.
A.A.F. Carioca, J. Steluti, A.M. Carvalho, et al., Plasma metabolomics are associated with metabolic syndrome: a targeted approach, Nutrition 83 (2021) 111082. https://doi.org/10.1016/j.nut.2020.111082.
C. Zhu, L. Sawrey-Kubicek, A.S. Bardagjy, et al., Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women, Nutri. Res. 78 (2020) 36-41. https://doi.org/10.1016/j.nutres.2020.04.002.
T. Requena, M. Miguel, M. Garcés-Rimón, et al., Pepsin egg white hydrolysate modulates gut microbiota in Zucker obese rats, Food & Function 8(1) (2017) 437-443. https://doi.org/10.1039/c6fo01571a.
X. Liang, Z. Zhang, Y. Lv, et al., Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis, Nutrition 79 (2020) 110941. https://doi.org/10.1016/j.nut.2020.110941.
G. Wang, W. Huang, Y. Xia, et al., Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice, Food & Function 10(3) (2019) 1684-1695. https://doi.org/10.1039/c8fo02181c.PMID:30839966.
P. Ferre, F. Foufelle, Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c, Diabetes, Obesity and Metabolism 12 (2010) 83-92. https://doi.org/10.1111/j.1463-1326.2010.01275.x.
C. Yan, J. Chen, N. Chen, Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability, Scientific Reports 6 (2016) 1-11. https://doi.org/10.1038/srep22640.
Z.W. Pei, Y. Guo, H.L. Zhu, et al., Thymoquinone protects against hyperlipidemia-induced cardiac damage in low-density lipoprotein receptordeficient (LDL-R-/-) mice via its anti-inflammatory and antipyroptotic effects, BioMed. Res. Intern. 2020 (2020) 4878704. https://doi.org/10.1155/2020/4878704.
C.W. Lin, Y.J. Peng, Y.Y. Lin, et al., LRRK2 regulates CPT1A to promote β-oxidation in HepG2 cells, Molecules 25(18) (2020) 4122. https://doi.org/10.3390/molecules25184122.
S. Shin, K. Ajuwon, Effects of diets differing in composition of 18-C fatty acids on adipose tissue thermogenic gene expression in mice fed high-fat diets. Nutrients 10(2) (2018) 256201. https://doi.org/10.3390/nu10020256.
K. Nonogaki, T. Kaji, Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet, Scientific Reports 10(1) (2020) 1-11. https://doi.org/10.1038/s41598-020-72975-8.
E. Szalowska, H.A. Tesfay, S.A. van Hijum, et al., Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology, BMC genomics 15(1) (2014) 11106. https://doi.org/10.1186/1471-2164-15-1106.
1135
Views
135
Downloads
0
Crossref
0
Web of Science
0
Scopus
0
CSCD
Altmetrics
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
